Pharmaceutical form: Vial 4 ML
Scientific name: Bevacizumab
Indications:
- Metastatic Colorectal Cancer: in combination with fluoropyrimidine-based chemotherapy
- Metastatic Colorectal Cancer: in combination with fluoropyrimidine-based chemotherapy
- Metastatic Breast Cancer: with paclitaxel for first-line treatment.
- Non squamous cell lung cancer: with carboplatin and paclitaxel for first line treatment of unresectable, locally advanced, recurrent or metastatic disease